McKesson Corporation (MCK) is a Medical - Distribution company in the Healthcare sector, currently trading at $862.79. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MCK = $1,623.29 (+88.1% from the current price, the stock appears undervalued). Analyst consensus target is MCK = $982 (+13.9% upside).
Valuation: MCK trades at a trailing Price-to-Earnings (P/E) of 24.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.88.
Financials: revenue is $359.1B, +10.9%/yr average growth. Net income is $3.3B, growing at +71.2%/yr. Net profit margin is 0.9% (thin). Gross margin is 3.7% (-1.3 pp trend).
Balance sheet: total debt is $7.4B with negative equity of -$2.1B — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.9 (tight liquidity). Debt-to-assets is 9.8%. Total assets: $75.1B.
Analyst outlook: 25 / 31 analysts rate MCK as buy (81%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 51/100 (Partial), Growth 90/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 55/100 (Partial), Future 82/100 (Pass), Income 30/100 (Fail).
